Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £16.37m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Issue of Equity

11 Mar 2026 11:10

RNS Number : 2458W
Sealand Capital Galaxy Limited
11 March 2026
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

11 March 2026

 

Sealand Capital Galaxy Limited

("Sealand" or the "Company")

 

Issue of Equity

Sealand Capital Galaxy Limited (LSE: SCGL) announces that it has entered into a subscription agreement with Mr. Siqi Cao, an Executive Director of the Company, pursuant to which Mr. Cao has conditionally agreed to subscribe for 444,371,233 new ordinary shares of £0.0001 each in the capital of the Company (the "Subscription Shares") at a price of £0.001 per Subscription Share (the "Subscription Price"), raising gross proceeds of approximately £444,371.23 (the "Subscription").

Related Party Transaction

Mr. Siqi Cao is an Executive Director of the Company and is therefore considered a related party for the purposes of Rule 7.3 of the Disclosure Guidance and Transparency Rules. Accordingly, the Subscription constitutes a material related party.

Mr. Cao did not participate in the Board's consideration of the Subscription or vote on the relevant Board resolution.

The independent Directors of the Company, being all Directors other than Mr. Cao, consider, having exercised reasonable care, skill and diligence, that the terms of the Subscription are fair and reasonable insofar as the shareholders of the Company who are not related parties are concerned.

The Board believes that the Subscription provides the Company with additional working capital and demonstrates continued support for the Company's strategy from a senior executive director

Issue of Shares

The Subscription and the issue of the Subscription Shares are conditional on Admission. The Company already has authority to issue the Subscription Shares, which was granted at its AGM on 10 January 2025 and remains in force.

At the date of this announcement, the Company had 1,011,534,756 ordinary shares in issue. If the Subscription completes in full, the Subscription Shares would represent approximately 30.5 per cent. of the Company's enlarged issued share capital.

Admission and Total Voting Rights

Application will be made for the Subscription Shares to be admitted to trading on the main market of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective and that dealings in the Subscription Shares will commence at 8.00am on or around 16 March 2026.

Following Admission, the total issued share capital of the Company will consist of 1,455,905,989 Ordinary Shares. Therefore, the total number of voting rights in the Company is 1,455,905,989 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest, in the share capital of the Company. 

Elena Law, Chairwoman of Sealand Capital Galaxy Limited, commented:

"We are pleased to see this continued commitment to the Company from one of our executive directors. The Board believes that securing additional working capital in a timely and cost-efficient manner is important as Sealand continues to develop its business and evaluate opportunities for growth. This subscription reflects confidence in the Company and our focus on building long-term value for shareholders."

The Directors of the Company are responsible for the release of this announcement.

 

Enquiries:

Sealand Capital Galaxy Limited

Elena Suet Sum Law (Chairwoman)

Dr. Thomas Sawyer (Chief Executive Officer)

Mr. Siqi Cao (Executive Director)

Geoffrey Griggs (Independent Non-executive Director)

Chong Sun Terng (Independent Non-Executive Director)

 

SPARK Advisory Partners Limited (Financial Adviser) +44 (0) 203 368 3550/3551

Mark Brady / Angus Campbell 

 

Media (PR/IR)

media@scglimited.info

 

Noted to the Editors:

The Company's Shares are traded on the Equity shares (transition) category of the London Stock Exchange under ticker LSE: SCGL.

Further information on Sealand Capital Galaxy limited is available on:

www.sealandcapitalgalaxy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJBMBTMTMBBPF
Date   Source Headline
30th Apr 20267:00 amRNSAssignment of CLN Investment in EVOO AI plc
29th Apr 20267:48 amRNSTemporary Suspension
30th Mar 202611:50 amRNSDirector/PDMR Shareholding
30th Mar 202611:38 amRNSCLN Conversion, Exercise of Warrants & TVR
26th Mar 202611:48 amRNSResult of General Meeting
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
11th Mar 202611:10 amRNSIssue of Equity
6th Mar 20264:54 pmRNSNotice of General Meeting
17th Feb 20267:00 amRNSAppointment of Financial Adviser
27th Jan 20264:00 pmRNSStrategic Update and Business Expansion
21st Jan 20264:00 pmRNSDirector Appointment and CFO Appointment
6th Jan 202612:43 pmRNSStatement re Share Price Movement
8th Dec 20253:00 pmRNSDirector Appointment
7th Nov 202512:05 pmRNSPublication of a Prospectus
30th Sep 20251:30 pmRNSHalf-year Report
22nd May 202510:22 amRNSExercise of Warrants
30th Apr 20255:00 pmRNSResults of General Meetings of Warrant Holders
30th Apr 20254:55 pmRNSFinal Results for the Year Ended 31 December 2024
25th Apr 20254:11 pmRNSNotice of General Meetings of Warrant Holders
14th Mar 20257:00 amRNS-REVOO AI PLC Appoints Gordon Radley as New Director
6th Mar 20257:00 amRNS-REVOO’s acceptance into the NVIDIA Connect Program
28th Feb 20254:33 pmRNS-RCEO Interviewed by StockBox Media
28th Feb 20257:00 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSSelection of Strategic Development Partner
24th Feb 20257:00 amRNS-RCorporate Update - Strategic Growth Initiatives
31st Jan 20254:32 pmRNSExercise of Convertible Loan Note and TVR
27th Jan 20257:00 amRNSFormation of ‘SEA-VOO AI ASIA’
20th Jan 20259:17 amRNSAppointment of Chief Executive Officer
10th Jan 20252:50 pmRNSAGM RESULTS AND INVESTMENT IN EVOO AI PLC
6th Jan 20253:24 pmRNSStatement re Share Price Movement
30th Dec 20247:00 amRNSConditional Issue of Equity and Issue of CLN
16th Dec 20247:00 amRNSNotice of AGM
4th Dec 20242:07 pmRNSShare Price Movement
22nd Nov 202410:08 amRNSConditional Investment Agreement
30th Sep 20247:00 amRNSInterim Results
11th Sep 20247:00 amRNSIssue of Equity
30th Apr 202412:30 pmRNSFinal Results
29th Jan 20247:00 amRNSIssue of Equity
29th Sep 20237:00 amRNSUnaudited Interim Results
16th Jun 20237:00 amRNSLifting of suspension, recommencement of trading
6th Jun 202310:11 amRNSREPLACEMENT: MOU WITH PARTNER IN GREATER CHINA
6th Jun 20239:13 amRNSMOU SIGNED WITH PARTNER IN GREATER CHINA
5th Jun 20233:02 pmRNSFinal results for the year ended 31 December 2022
2nd May 20237:57 amRNSDELAY IN PUBLISHING AUDITED FINANCIAL STATEMENTS
17th Apr 20237:00 amRNSHH Simonsen distributorship agreement update
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSIssue of Equity
27th Sep 20227:00 amRNSUnaudited Interim Results
30th Jun 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.